-
Aspirin, Higher Doses No More Effective, Risky; Subclinical Hypothyroidism Treatment Benefits; FDA approvals
-
This was a retrospective small case control study that looked at 115 HTLV-1 infected patients from the state of Bahia in Northeastern Brazil who were originally found to be HTLV-1 infected at the time of blood donation and were later followed in a special clinic.
-
Over the last 15 years increased understanding of the complicated process of HIV attachment and entry into host cells has developed.
-
Since shortly after the return of the first U.S. casualties wounded in Iraq in early 2003 to the United States, significant numbers of infections due to often multidrug-resistant Acinetobacter species have been observed in these patients shortly after arriving back in tertiary care military hospitals in the continental U.S. (CONUS).
-
Brown and colleagues evaluated the most efficient means of microbiological diagnosis of tuberculosis in patients.
-
The lead II rhythm strip image in this article was obtained from a middle-aged man in cardiac arrest. The patient had multiple co-morbidities ...
-
The FDA has approved a transdermal patch for the treatment of early Parkinson's disease. Rotigotine is a non-ergoline, D3/D2/D1 dopamine receptor agonist. It is marketed by Schwarz Bioscience as Neupro.
-
Standard 10 day triple therapy for Helicobacter pylori may result in relatively low eradication rates. An alternative regimen of PPI plus amoxicillin for 5 days followed by PPI plus clarithromycin plus tinidazole for five days seems to provide significantly better H. pylori eradication.
-
Higher incidence of benign leukopenia from lower neutrophil counts is found in black persons compared to white in the United States, and Mexican-Americans and smokers have slightly higher routine counts.
-